These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2887185)

  • 1. Pharmacokinetics of isoxicam in hepatic disease.
    Ferry N; Cuisinaud G; Ouzan D; Trepo C; Sassard J
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):143S-147S. PubMed ID: 2887185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of isoxicam pharmacokinetics in young and elderly subjects.
    George CF; Renwick AG; Darragh AS; Hosie J; Blake D; van Marle W; Frank GJ
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):129S-134S. PubMed ID: 3620272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of administration of phenytoin on the pharmacokinetics of isoxicam.
    Caillé G; Du Souich P; Larivière L; Vézina M; Lacasse Y
    Biopharm Drug Dispos; 1987; 8(1):57-61. PubMed ID: 3580513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.
    Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J
    Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency.
    Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L
    Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of impairment of renal function on the accumulation and disposition of isoxicam.
    Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF
    Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disposition of the non-steroidal anti-inflammatory agent isoxicam in man.
    Woolf TF; Black A; Sedman A; Chang T
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):21-7. PubMed ID: 1499594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis.
    Grace EM; Rosenfeld JM; Sweeney GD; Buchanan WW
    Curr Med Res Opin; 1987; 10(9):580-91. PubMed ID: 3436154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
    Grace EM; Mewa AA; Sweeney GD; Rosenfeld JM; Darke AC; Buchanan WW
    J Rheumatol; 1986 Dec; 13(6):1119-21. PubMed ID: 3560102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single and multiple dose pharmacokinetics of tenoxicam in the elderly.
    Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E
    Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam.
    Edwards IR; Ferry DG; Campbell AJ
    Eur J Clin Pharmacol; 1985; 28(6):689-92. PubMed ID: 4065194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tenoxicam concentrations after single and multiple oral doses.
    Crevoisier C; Heizmann P; Forgo I; Dubach UC
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tenoxicam at different dosage regimes.
    Scaglione F; Demartini G; Dugnani S; Fraschini F; Triscari FA
    Farmaco; 1993 Sep; 48(9):1321-5. PubMed ID: 8259988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of isoxicam in the elderly.
    Buchanan WW; Grace EM
    Am J Med; 1985 Oct; 79(4B):35-7. PubMed ID: 4061466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of isoxicam with acetylsalicylic acid.
    Esquivel M; Cussenot F; Ogilvie RI; East DS; Shaw DH
    Br J Clin Pharmacol; 1984 Oct; 18(4):567-71. PubMed ID: 6487496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tenoxicam in healthy human volunteers.
    Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
    Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of administration of propranolol on the pharmacokinetics of isoxicam.
    Caillé G; Larivière L; Lacasse Y; Vézina M; Besner JG
    Biopharm Drug Dispos; 1986; 7(1):63-9. PubMed ID: 3955200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.